DeepMed Research

Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Biomarkers Guided Stopping NAs Treatment

Not Applicable

Conditions: Chronic Hepatitis b

Interventions: Other: Stop NAs therapy

First Posted Date: 2020-08-19

Last Posted Date: 2020-08-19

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 195

Registration Number: NCT04519359

Locations: 🇨🇳
No. 1 Hospital affiliated to Jilin University, Chang chun, Jilin, China
🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China

and more 2 locations

Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation

Phase 4

Conditions: Hydromorphone
Analgesia
ICU

Interventions: Drug: Hydromorphone
Drug: Fentanyl
Drug: Butorphanol

First Posted Date: 2020-06-17

Last Posted Date: 2022-01-20

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 530

Registration Number: NCT04436224

Locations: 🇨🇳
Southern medical university Nanfang hospital, Guangzhou, China

Blood Pressure Management on Cardiovascular AdveRse Events After Major Abdominal Surgery

Not Applicable

Completed

Conditions: Cardiovascular Complication

Interventions: Other: Intensive intraoperative blood pressure management
Other: Conventional intraoperative blood pressure management

First Posted Date: 2020-06-16

Last Posted Date: 2025-04-22

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 1500

Registration Number: NCT04430920

Locations: 🇨🇳
Xinqiao Hospital of Chongqing, Chongqing, Chongqing, China
🇨🇳
Southern Medical University Nanfang Hospital, Guangzhou, China
🇨🇳
Henan Provincial People's Hospital, Zhengzhou, China

Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML

Phase 2

Completed

Conditions: Refractory Acute Myeloid Leukemia
Salvage Treatment
Relapsed Acute Erythroid Leukemia
HVA Regimen

Interventions: Combination Product: HVA Regimens as Salvage Treatment

First Posted Date: 2020-06-09

Last Posted Date: 2022-10-26

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 96

Registration Number: NCT04424147

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Cardio-Cerebrovascular Co-Prevention and Co-Management Based on Internet+

Not Applicable

Conditions: Cardiovascular Diseases
Stroke
Myocardial Ischemia
Cerebrovascular Disorders
Internet-Based Intervention

Interventions: Behavioral: Establishment of individual health records
Behavioral: Cardiovascular risk assessment
Behavioral: Popularization of medical knowledge
Behavioral: Personalized Reminders
Drug: Routine treatment

First Posted Date: 2020-06-01

Last Posted Date: 2020-06-01

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 8840

Registration Number: NCT04409210

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Cancer-associated Gene Mutations in CML Treatment With TKIs by NGS

Conditions: Different Gene Between Different TKIs Effection

Interventions: Genetic: different effection

First Posted Date: 2020-02-18

Last Posted Date: 2022-04-12

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 100

Registration Number: NCT04274231

Locations: 🇨🇳
NanfangH, Guangzhou, Guangdong, China

Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer

Phase 2

Conditions: Colorectal Cancer

Interventions: Combination Product: Single incision plus one port laparoscopic surgery

First Posted Date: 2020-02-13

Last Posted Date: 2020-02-13

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 120

Registration Number: NCT04268290

Studying on the Difference Between Two Kinds of Osteomyelitis

Completed

Conditions: Diabetic Foot Osteomyelitis
Diabetic Foot Infection
Microbiome

First Posted Date: 2020-01-27

Last Posted Date: 2020-01-27

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 28

Registration Number: NCT04240964

Locations: 🇨🇳
Department of Endocrinology and Metabolism, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China

The Diagnosis of Invasive Depth of Early Rectal Cancer

Not Applicable

Conditions: Early Rectal Cancer

Interventions: Diagnostic Test: Linear EUS first
Diagnostic Test: ME-NBI first

First Posted Date: 2020-01-10

Last Posted Date: 2020-01-10

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 81

Registration Number: NCT04222530

Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma

Phase 2

Recruiting

Conditions: Nasopharyngeal Carcinoma
Radiotherapy
Oligometastasis

Interventions: Drug: Camrelizumab

First Posted Date: 2020-01-09

Last Posted Date: 2023-06-18

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 52

Registration Number: NCT04221516

Locations: 🇨🇳
Southern medical university, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy